4//SEC Filing
Wirostko Barbara 4
Accession 0001144204-17-048266
CIK 0001372514other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 4:29 PM ET
Size
8.8 KB
Accession
0001144204-17-048266
Insider Transaction Report
Form 4
Wirostko Barbara
Chief Medical Officer
Transactions
- Award
Common Stock
2017-09-14$1.23/sh+9,000$11,070→ 50,700 total(indirect: By Spouse) - Award
Common Stock
2017-09-15$1.20/sh+9,000$10,800→ 228,042 total - Award
Common Stock
2017-09-14$1.22/sh+1,200$1,464→ 219,042 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.22 to $1.24, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.19 to $1.21, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001669087
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 4:29 PM ET
- Size
- 8.8 KB